Overview
Updated 14 Jul 2026
Roger Shapiro, MD, is Professor of Immunology and Infectious Diseases at Harvard T.H. Chan School of Public Health, Department of Immunology and Infectious Diseases. The public record shows 282 publications with 13,317 citations (h-index 51), centered on HIV/AIDS Research and Interventions, HIV Research and Treatment, HIV/AIDS drug development and treatment. It also documents an investigator role on 6 registered clinical trials, 12 NIH-funded awards (2000–2025).
- Most recent indexed publication: 2026 · Clinical infectious diseases
- Top research focus: HIV/AIDS Research and Interventions
- 6 registered trials on ClinicalTrials.gov
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 10 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 144.
Clinical & industrytrials, payments and federal funding
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 6 registered studies on ClinicalTrials.gov. The most recent:
- POC HIV Testing and Early DTG Use for Infants
Sponsor: Harvard School of Public Health (HSPH)
InvestigatorPhase 4Active, not recruitingNCT05393193 - Dual bNAb Treatment in Children
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
InvestigatorPhase 1/PHASE2CompletedNCT03707977 - Early Infant HIV Treatment in Botswana
Sponsor: Harvard School of Public Health (HSPH)
InvestigatorPhase 2/PHASE3Active, not recruitingNCT02369406
Industry payments
No payments involving this person were reported to CMS in program years 2021–2024. Why? →
NIH funding
Updated 14 Jul 2026
12 NIH research awards on record, funded 2000–2025 per NIH RePORTER. The latest:
- Training in HIV Genomics, Treatment, and Cure Research in Botswana
the Botswana Harvard Health Partnership
FY2026$301,201D43TW009610 - A Clinical Trial of Three Broadly Neutralizing Antibodies and Analytic Treatment Interruption in Early-Treated Children in Botswana
Harvard University D/b/a Harvard School of Public Health
FY2025$1,311,671U01AI179561 - A Clinical Trial of Three Broadly Neutralizing Antibodies and Analytic Treatment Interruption in Early-Treated Children in Botswana
Harvard University D/b/a Harvard School of Public Health
FY2025$889,638U01AI179561
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Lamivudine dosing for preterm infants exposed to HIV: a population pharmacokinetic modelling and simulation study.
The Journal of antimicrobial chemotherapy
2024 - Low Prevalence of Nirmatrelvir-Ritonavir Resistance-Associated Mutations in SARS-CoV-2 Lineages From Botswana.
Open forum infectious diseases
2024
Most-cited worksby citation count (OpenAlex)
- 01
- 02Antiretroviral Regimens in Pregnancy and Breast-Feeding in Botswana520 citations2010
- 03Botulism in the United States: A Clinical and Epidemiologic Review513 citations1998
- 04Adaptation of HIV-1 to human leukocyte antigen class I471 citations2009
- 05
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
651 Huntington Ave, FXB 402, Boston, MA 02115
Network
Updated 14 Jul 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- MD
New York University School of Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →findadoc.bidmc.org ↗ - MPH
Harvard T.H. Chan School of Public Health
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cfar.globalhealth.harvard.edu ↗ - Board Certified
Infectious Disease (American Board of Internal Medicine)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →findadoc.bidmc.org ↗
Editorial & leadership rolesjournal and society appointments
- Principal Investigator
Early Infant Treatment Study and Tatelo Study (broadly neutralizing monoclonal antibody treatment in HIV-affected children), Botswana
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →science.org ↗ - Head
Shapiro Research Group, Harvard T.H. Chan School of Public Health
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hsph.harvard.edu ↗
Awards & honorshonors on the public record
- Principal Investigator
NIH K24 Award (K24-AI131924), Expansion of research and mentoring to improve birth and treatment outcomes among HIV-affected children in Botswana
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →grantome.com ↗ - Principal Investigator
Fogarty International Center award supporting the Clinical Care and Research Fellowship at Scottish Livingstone Hospital, Molepolele, Botswana
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →news.harvard.edu ↗
Secondary affiliationsappointments beyond the home institution
- Physician
Division of Infectious Diseases, Beth Israel Deaconess Medical Center; Professor of Medicine, Harvard Medical School
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hsph.harvard.edu ↗ - Botswana Harvard Health Partnership (BHP)
faculty/governing role, Molepolele/Gaborone, Botswana
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bhp.org.bw ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cfar.globalhealth.harvard.edu ↗
Media & interviewspress, podcasts and appearances
- "Setback in the fight against pediatric HIV"
Harvard Gazette feature quoting Shapiro on antibody combination treatment trial
2025verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.harvard.edu ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hsph.harvard.edu ↗
- "Beginning of end of HIV epidemic?"
Harvard Gazette feature on lenacapavir and HIV treatment/prevention, quoting Shapiro
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.harvard.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by otherswhere others cite or feature them
- Other
bhp.org.bw/node/18
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bhp.org.bw ↗ - Other
cfar.globalhealth.harvard.edu/directory/roger-l-shapiro-md-mph
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cfar.globalhealth.harvard.edu ↗ - Other
hsph.harvard.edu/roger-shapiro
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hsph.harvard.edu ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Paul Richardson, MD
Harvard University
- 2,062
- publications
- 172
- h-index
- 17
- trials
Pasi Janne, MD, PhD
Harvard University
- 2,385
- publications
- 163
- h-index
- 15
- trials
Steven Greenberg, MD
Harvard University
- 954
- publications
- 144
- h-index
- 9
- trials
David Scadden, MD
Harvard University
- 665
- publications
- 124
- h-index
- 4
- trials